42
Participants
Start Date
October 7, 2020
Primary Completion Date
September 3, 2022
Study Completion Date
September 3, 2022
Infectious Clinical Hosp #1 /ID# 225063, Moscow
LLC Center of Targeted Therapy /ID# 239529, Domodedovo
Saint-Petersburg AIDS Center /ID# 239357, Saint Petersburg
S. P. Botkin City Hospital /ID# 229510, Oryol
Specialized Clinical Infectious Diseases Hospital /ID# 229814, Krasnodar
Stavropol State Medical University /ID# 243216, Stavropol
Samara Region Clinical HIV/AIDS Prevention and Control Center /ID# 226591, Samara
South Ural State Medical University /ID# 226555, Chelyabinsk
Infectious Clinical Hospita l#2 /ID# 243217, Nizhny Novgorod
Irkutsk Regional Center for the Prevention and Control of AIDS and Infections /ID# 229509, Irkutsk
Lead Sponsor
AbbVie
INDUSTRY